Enterprise Financial Services Corp (EFSC)’s West Pharmaceutical WST Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-718	Closed	-$305K	–	467
2021 Q3	$305K	Buy	718 +698	+3,490%	+$294K	0.04%	245
2021 Q2	$7K	Hold	20	–	–	﹤0.01%	861
2021 Q1	$6K	Buy	20 +10	+100%	+$2.86K	﹤0.01%	904
2020 Q4	$3K	Buy	10 +3	+43%	+$842	﹤0.01%	1038
2020 Q3	$2K	Hold	7	–	–	﹤0.01%	1118
2020 Q2	$2K	Hold	7	–	–	﹤0.01%	1120
2020 Q1	$1K	Buy	+7	New	+$1.08K	﹤0.01%	1241
2018 Q2	–	Sell	-12	Closed	-$1K	–	988
2018 Q1	$1K	Buy	+12	New	+$1.12K	﹤0.01%	929
2015 Q2	–	Sell	-22	Closed	-$1K	–	1221
2015 Q1	$1K	Hold	22	–	–	﹤0.01%	1210
2014 Q4	$1K	Hold	22	–	–	﹤0.01%	1220
2014 Q3	$1K	Hold	22	–	–	﹤0.01%	1192
2014 Q2	$1K	Hold	22	–	–	﹤0.01%	1204
2014 Q1	$1K	Hold	22	–	–	﹤0.01%	1230
2013 Q4	$1K	Hold	22	–	–	﹤0.01%	1152
2013 Q3	$1K	Buy	+22	New	+$839	﹤0.01%	1174

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s WST Position: Q4 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 718 shares — an estimated $305K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in WST in Q3 2013 and held it in 15 quarters. The position peaked at $305K in Q3 2021. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

Enterprise Financial Services Corp (EFSC) reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 718 West Pharmaceutical shares in Q4 2021, an estimated $305K.
Enterprise Financial Services Corp (EFSC) first reported a position in West Pharmaceutical in Q3 2013 and held it in 15 quarters.
Enterprise Financial Services Corp (EFSC)'s West Pharmaceutical position peaked at $305K in Q3 2021.
729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2021, filed 14 Feb 2022.